Natural dual inhibitor isorhamnetin-3-O-neohespeidoside targets tyrosinase and MC1R for skin pigmentation management

Thermo FisherJim Cramer on Thermo Fisher: “I Think That the Market Has This Wrong” - Yahoo Finance

10x Genomics Blog10x Genomics' Insiders' Timely Sale May Have Helped Mitigate 15% Dip in Share Price - Moomoo

AgilentAgilent Technologies Inc. stock (US00846U1016): Why its life sciences leadership matters more now fo - AD HOC NEWS

Thermo FisherVanguard Group Inc. Has $19.78 Billion Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat

Thermo FisherIs Thermo Fisher Scientific (TMO) Offering Value After Recent Share Price Weakness - simplywall.st

10x Genomics BlogQ3 2025 10X Genomics Inc Earnings Call Transcript - GuruFocus

10x Genomics Blog10X Genomics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

10x Genomics BlogCash-Rich Stocks: 10x Genomics, Novavax, and Powell Analysis | April 2026 - News and Statistics - IndexBox

IlluminaDid DRAGEN v4.5’s AI Genomics Push Just Shift Illumina’s (ILMN) Investment Narrative? - simplywall.st

Brady CorporationBrady to acquire Honeywell unit for $1.4B - MSN

Thermo FisherThermo Fisher Scientific Inc. $TMO Shares Purchased by Munich Reinsurance Co Stock Corp in Munich - MarketBeat